WHO agency says talc is 'probably' cancer-causing

WHO agency says talc is 'probably' cancer-causing

Johnson & Johnson removed its baby powder from the North American market in 2020 after talc came under greater scrutiny for causing cancer
Johnson & Johnson removed its baby powder from the North American market in 2020 after talc came under greater scrutiny for causing cancer. Photo: FREDERIC J. BROWN / AFP/File
Source: AFP

The World Health Organization's cancer agency on Friday classified talc as "probably carcinogenic" for humans, however an outside expert warned against misinterpreting the announcement as a "smoking gun".

The decision was based on "limited evidence" talc could cause ovarian cancer in humans, "sufficient evidence" it was linked to cancer in rats and "strong mechanistic evidence" that it shows carcinogenic signs in human cells, the WHO's International Agency for Research on Cancer (IARC) said.

Talc is a naturally occurring mineral which is mined in many parts of the world and is often used to make talcum baby powder.

Most people are exposed to talc in the form of baby powder or cosmetics, according to the Lyon-based IARC.

But the most significant exposure to talc occurs when talc is being mined, processed or used to make products, it added.

Read also

Single and proud: S. Korean YouTuber's viral embrace of solo life

The agency said there were numerous studies which consistently showed an increase in the rate of ovarian cancer in women who use talc on their genitals.

But it could not rule out that the talc in some studies was contaminated with cancer-causing asbestos.

"A causal role for talc could not be fully established," according the agency's findings published in The Lancet Oncology.

Kevin McConway, a statistician at the UK's Open University not involved the research, warned that for the IARC's evaluation, the "most obvious interpretation is actually misleading".

The agency is only aiming "to answer the question of whether the substance has the potential to cause cancer, under some conditions that IARC do not specify," he said.

Because the studies were observational and so could not prove causation, "there isn’t a smoking gun that the talc use causes any increased cancer risk," he added.

Read also

Biden calls for lower prices of Ozempic, similar drugs

The announcement comes just weeks after US pharmaceutical and cosmetics giant Johnson & Johnson agreed to pay $700 million to settle allegations it misled customers about the safety of its talcum-based powder products.

Johnson & Johnson did not admit wrongdoing in its settlement, even though it withdrew the product from the North American market in 2020.

A summary of studies published in 2020 covering 250,000 women in the United States did not find a statistical link between the use of talc on the genitals and the risk of ovarian cancer.

Also on Friday, the IARC classified acrylonitrile, a chemical compound used to make polymers, as "carcinogenic to humans", its highest warning level.

It cited "sufficient evidence" linking acrylonitrile to lung cancer.

The polymers made with acrylonitrile are used in everything from fibres in clothes to carpets, plastics and other consumer products.

Source: AFP

Authors:
AFP avatar

AFP AFP text, photo, graphic, audio or video material shall not be published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium. AFP news material may not be stored in whole or in part in a computer or otherwise except for personal and non-commercial use. AFP will not be held liable for any delays, inaccuracies, errors or omissions in any AFP news material or in transmission or delivery of all or any part thereof or for any damages whatsoever. As a newswire service, AFP does not obtain releases from subjects, individuals, groups or entities contained in its photographs, videos, graphics or quoted in its texts. Further, no clearance is obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP material. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP material.